Skip to content

Time Limited Eating in Adolescents (Time LEAd): a Pilot Study

Time Limited Eating in Adolescents (Time LEAd): a Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03954223
Acronym
TimeLEAd
Enrollment
50
Registered
2019-05-17
Start date
2020-03-01
Completion date
2022-03-01
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Childhood

Brief summary

The investigators propose a randomized controlled trial in 90 children (age 13-21y) with obesity recruited from clinical programs at the Children's Hospital Los Angeles (CHLA). Patients will be randomized to one of three treatment groups for a 12-week intervention: Group 1) Low sugar and carbohydrate diet (LSC, \<90 gm carbohydrate (CHO)/day, \<25 gm added sugar/day) + blinded CGM (used to monitor adherence and glycemic outcomes without real time feedback). Group 2) LSC+TLE (16-hour fast/8-hour feed for 3 days per week) + blinded CGM, Group 3) LSC+TLE+ real time feedback via CGM (to evaluate effect of providing CGM data on intervention efficacy).

Detailed description

The majority of adolescents with obesity demonstrate declining beta cell (β-cell) function and progressive insulin resistance over their lifetime.1 In our population of lower income minority teens, 1 in 3 have obesity or severe obesity and of those 30-50% go on to develop PD or T2D during adolescence or as young adults.1 Although diet and increased adiposity play a significant role in the pathogenesis of these conditions, the standard treatment model of intensive lifestyle modifications often result in modest decrease in BMI z-score of -0.1-0.2 SD.2, 3 There is a paucity of trials that have examined the effect of time limited eating (TLE) interventions in the treatment of youth with obesity.4 Novel dietary approaches like time limited eating have been shown to be effective for weight loss and improved glycemic control in adults with obesity but have not been examined in children.5, 6 A TLE approach involves interspersing normal daily caloric intake with 16-hour periods of calorie restriction/fasting several times a week.7-9 TLE may actually be more feasible, non-stigmatizing, flexible and effective for adolescents than alternatives like severe caloric restriction because it removes the need for intensive counting of daily caloric intake or macronutrient content and focuses on a straightforward task of consuming food during a pre-specified time period.4, 10, 11 One major limitation to implementing any dietary intervention in pediatric populations is concern for poor adherence and difficulty in reliably assessing compliance. We aim to overcome these issues with the use of continuous glucose monitoring (CGM) to monitor and promote adherence to the intervention and thus improve overall efficacy. In addition, the use of CGM will provide important outcome data related to overall glycemic response. Finally, we will evaluate whether providing individual feedback based on CGM data to subjects as real time biofeedback as part of the intervention, enhances efficacy. We propose a randomized controlled trial in 60 children (age 14-18) with obesity (BMI% \> 95th percentile) recruited from clinical programs at the Children's Hospital Los Angeles (CHLA). Patients will be randomized to one of three treatment groups for a 12-week intervention: Group 1) Low sugar and carbohydrate diet (LSC, \<90 gm carbohydrate (CHO)/day, \<25 gm added sugar/day) + blinded CGM (used to monitor adherence and glycemic outcomes without real time feedback). Group 2) LSC+TLE (16-hour fast/8-hour feed for 5 days per week) + blinded CGM, Group 3) LSC+TLE+ real time feedback via CGM (to evaluate effect of providing CGM data on intervention efficacy). We have 3 Specific Aims: Aim 1. Test the efficacy of adding a TLE approach to a LSC intervention on body fat and weight loss (Group 2 vs. Group 1). Hypothesis 1: LSC+TLE will result in greater decrease in body fat and zBMI than LSC alone. Aim 2. Test the efficacy of LSC+TLE compared to LSC alone on reduction on glycemic response (CGM) and psychosocial parameters (Group 2 vs. Group 1). Hypothesis 2: TLE+LSC will result in a greater improvement in glucose control (FBG) and psychosocial parameters. Aim 3. Evaluate if CGM use is a feasible tool to determine dietary compliance to TLE type interventions and determine the impact of unblinded CGM on dietary intervention adherence and efficacy (Group 3 vs. Group 2). Hypothesis 3a: CGM will be a feasible tool to determine dietary compliance. Hypothesis 3b: Unblinded CGM data will result in 1) improved adherence to the dietary intervention as assessed by percent time in range when compared to those wearing a blinded CGM and 2) improve intervention effects. Overall Impact: This research will generate new knowledge that can readily be integrated into clinical weight management programs to optimize their impact and accelerate healthy changes for youth with obesity. This dietary intervention could lead to global improvement and result in slowed disease progression, decreased complications and reduced prevalence of secondary comorbidities that arise from a lifetime of obesity. Virtual Adaptation: To respond to the COVID-19 research restriction the study protocol was adapted for a 100% virtual model in which all study procedures, consent and outcome measures were collected virtually. For this cohort the aim was to recruit 10-12 completer per study arm with a maximum anticipated recruitment of 20-30 adolescents per group. For the virtual adaptation there is no DEXA scan or blood testing that is collected due to the in-person restriction.

Interventions

BEHAVIORALLow sugar and carbohydrate diet

Low sugar and carbohydrate diet (LSC, \<90 gm carbohydrate (CHO)/day, \<25 gm added sugar/day)

16-hour fast/8-hour feed for 3 days per week

DEVICEContinuous Glucose Monitor

CGM (used to monitor adherence and glycemic outcomes without real time feedback)

Sponsors

Children's Hospital Los Angeles
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
14 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

1. age 14-18 2. BMI\> 85th percentile 3. parent, guardian or family member ages 18 years and older willing to participate

Exclusion criteria

* Insulin requirement 1. previous diagnosis of Prader Willi Syndrome, brain tumor or hypothalamic obesity 2. serious mental conditions (e.g. developmental or intellectual disability or previously diagnosed eating disorder or positive screen at consent visit) 3. physical, mental of other inability to participate in the assessments (e.g. inability to wear CGM, inability to be in the imaging modality without sedation, or inability to eat by mouth) 4. previous or planned bariatric surgery 5. current use of medication that impacts weight or executive functioning (e.g., antipsychotics, sedatives, hypnotics, off-label obesity medication) 6. current psychotherapy regarding weight or eating behavior 7. current participation in other interventional studies. In our experience, children younger than 13 years of age and older than 21 years would require different intervention/counseling strategies.

Design outcomes

Primary

MeasureTime frameDescription
Percent Change in BMI in Excess of the 95th Percentile (%BMIp95)%BMIp95 at Week 12 minus %BMIp95 at baselinePercent Change in BMI in excess of the 95th percentile (%BMIp95) as calculated by the CDC extended SAS equations at week 12 minus %BMIp95 at baseline. For example If the BMI is greater than the 95th percentile: BMI percentile equals 90 plus 10 times the cumulative distribution function (CDF) of the standard normal distribution. Sigma is the value from the data table corresponding to the sex of the child and the age in months. and are the cumulative distribution function (CDF) of the standard normal distribution and its inverse function. Standard normal distribution tables can be found in statistics textbooks, online sources, and statistical computer programs. Example: A boy aged 4 years and 2 months (50.5 months) with BMI = 22.6. For this boy, P95 (95th percentile) is 17.8219 so his BMI is above the 95th percentile and sigma = 2.3983.

Secondary

MeasureTime frameDescription
Average GlucoseChange in average glucose at week 12 minus average glucose at baselineAffect of TRE on change in average glucose

Countries

United States

Participant flow

Participants by arm

ArmCount
LSC + Blinded CGM
Group 1) Low sugar and carbohydrate diet (LSC, \<90 gm carbohydrate (CHO)/day, \<25 gm added sugar/day) + blinded CGM (used to monitor adherence and glycemic outcomes without real time feedback) Low sugar and carbohydrate diet: Low sugar and carbohydrate diet (LSC, \<90 gm carbohydrate (CHO)/day, \<25 gm added sugar/day) Continuous Glucose Monitor: CGM (used to monitor adherence and glycemic outcomes without real time feedback)
15
LSC+TLE + Blinded CGM
Group 2) LSC+Time limited eating (TLE) (16-hour fast/8-hour feed for 3 days per week) + blinded CGM Low sugar and carbohydrate diet: Low sugar and carbohydrate diet (LSC, \<90 gm carbohydrate (CHO)/day, \<25 gm added sugar/day) Time Limited Eating: 16-hour fast/8-hour feed for 3 days per week Continuous Glucose Monitor: CGM (used to monitor adherence and glycemic outcomes without real time feedback)
19
LSC+TLE+ Real Time Feedback Via CGM
Group 3) LSC+TLE+ real time feedback via CGM (to evaluate effect of providing CGM data on intervention efficacy). Low sugar and carbohydrate diet: Low sugar and carbohydrate diet (LSC, \<90 gm carbohydrate (CHO)/day, \<25 gm added sugar/day) Time Limited Eating: 16-hour fast/8-hour feed for 3 days per week Continuous Glucose Monitor: CGM (used to monitor adherence and glycemic outcomes without real time feedback)
16
Total50

Baseline characteristics

CharacteristicLSC + Blinded CGMLSC+TLE + Blinded CGMLSC+TLE+ Real Time Feedback Via CGMTotal
Age, Categorical
<=18 years
15 Participants19 Participants16 Participants50 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants0 Participants
Age, Continuous16.38 year
STANDARD_DEVIATION 1.25
16.16 year
STANDARD_DEVIATION 1.16
16.80 year
STANDARD_DEVIATION 1.09
16.80 year
STANDARD_DEVIATION 1.09
BMI Z-score2.30 Z-score
STANDARD_DEVIATION 0.5
2.28 Z-score
STANDARD_DEVIATION 0.4
2.30 Z-score
STANDARD_DEVIATION 0.5
2.30 Z-score
STANDARD_DEVIATION 0.5
Ethnicity (NIH/OMB)
Hispanic or Latino
7 Participants15 Participants13 Participants35 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
8 Participants4 Participants3 Participants15 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants
Region of Enrollment
United States
15 Participants19 Participants16 Participants50 Participants
Sex: Female, Male
Female
12 Participants13 Participants11 Participants36 Participants
Sex: Female, Male
Male
3 Participants6 Participants5 Participants14 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 150 / 190 / 16
other
Total, other adverse events
0 / 150 / 190 / 16
serious
Total, serious adverse events
0 / 150 / 190 / 16

Outcome results

Primary

Percent Change in BMI in Excess of the 95th Percentile (%BMIp95)

Percent Change in BMI in excess of the 95th percentile (%BMIp95) as calculated by the CDC extended SAS equations at week 12 minus %BMIp95 at baseline. For example If the BMI is greater than the 95th percentile: BMI percentile equals 90 plus 10 times the cumulative distribution function (CDF) of the standard normal distribution. Sigma is the value from the data table corresponding to the sex of the child and the age in months. and are the cumulative distribution function (CDF) of the standard normal distribution and its inverse function. Standard normal distribution tables can be found in statistics textbooks, online sources, and statistical computer programs. Example: A boy aged 4 years and 2 months (50.5 months) with BMI = 22.6. For this boy, P95 (95th percentile) is 17.8219 so his BMI is above the 95th percentile and sigma = 2.3983.

Time frame: %BMIp95 at Week 12 minus %BMIp95 at baseline

ArmMeasureValue (MEAN)Dispersion
LSC + Blinded CGMPercent Change in BMI in Excess of the 95th Percentile (%BMIp95)-3.27 percentStandard Deviation 3.34
LSC+TLE + Blinded CGMPercent Change in BMI in Excess of the 95th Percentile (%BMIp95)-3.76 percentStandard Deviation 5.76
LSC+TLE+ Real Time Feedback Via CGMPercent Change in BMI in Excess of the 95th Percentile (%BMIp95)-4.85 percentStandard Deviation 5.08
p-value: 0.4ANOVA
Secondary

Average Glucose

Affect of TRE on change in average glucose

Time frame: Change in average glucose at week 12 minus average glucose at baseline

ArmMeasureValue (MEAN)
LSC + Blinded CGMAverage Glucose0.5 mg/dL
LSC+TLE + Blinded CGMAverage Glucose-7.1 mg/dL
LSC+TLE+ Real Time Feedback Via CGMAverage Glucose-4.2 mg/dL
p-value: 0.2Regression, Linear

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026